 Today, I have the pleasure of speaking with Stuart Lothar from Element Nutritional Sizes. How are you today? I'm awesome. Thank you. How are you? Well, I'll tell you. We love the elements. We work in the rarest all the time, but you're a different kind of element. You're a nutritional company that is focused on people over the age of 50. Is that correct? That is correct. We're dialed right in to everybody, basically 45 and up. So the key aging demographic, which makes up the biggest part of our population base. So what our investor Intel audience will appreciate is this last week, the market's been a little rocky, but your stock has held firm. In fact, I've actually tweeted about that a couple of times. So your shareholders believe in the fundamentals of your company. And I noticed you just put out news releases last week on another innovative sports nutrition product. Why don't we start there? Sure. Basically, off that press release, we've put together a new formulation that's based off our patented IP. And we acquired the rights for the sports nutrition market in the US market. It's about a $30 billion market. And our new product that we've put together that we're going to be launching in the US is very innovative. It's very unique. There's nothing like on the marketplace. So we're taking this IP and we're going to push it forward into that market. Okay. So I feel like I'm having one of those conversations. You know where you don't know the person's name and you're trying to hint for them to give it to you? I can't pronounce your new product. It's under this new brand. Can you please pronounce that for our audience? So JackedRX is the brand. And the new product that's coming out in the United States is called Promenal. Okay. So it's called Jack TRX. Is that correct? JackedRX. So the RX. JackedRX. Okay. RX for prescription pharmaceutical, JackedRX. And this product, tell me a little bit more what it actually does because I'm over 50 and I'm interested in all your products. Well, this particular product, we have clinical data that shows we can increase muscle protein synthesis by 76%. So it's more effective than even taking whey protein. So whey protein, which is a very large market used by the whole fitness industry globally. This is actually more effective in helping your body build muscle than taking a whey protein shake. Okay. So this is a protein powder, basically. Well, not exactly. We've taken the best parts of protein and extracted them and concentrated them into an ideal formulation that is more effective than taking protein by itself. Well, I also do protein shakes every day and I'll be tweeting about this. How do I get this protein powder? It's my understanding I have to be in the US to get this at this time. Is that correct? At this time, you have to be in the United States to get it. But you're listed on the Canadian market, correct? We have applications in with Health Canada. So we expect to have what's called our natural product number for this product in the next four to six months. As soon as we have that, we'll start launching it here in Canada. And let me also add, for those of you out there, and I know there are plenty because our investment, our investor talk that we host regularly has a number of vegetarians. This is all plant-based, correct? That is correct. All the amino acids that we have in our formulation are all plant-based. And of course, you're intensely busy. So we're so delighted to have this interview update. So I'm going to ask you a couple of questions very quickly, starting with your, you also just announced a medical advisory board. Can you give us some highlights on that, please? Well, the big highlight is not only the experience of the peel we brought on board, but we're now moving forward with our long-term plans to be into the musculoskeletal category in orthopedics, as well as moving forward with some clinical research in oncology, because we're very confident that we can help slow musculoskeletal and cancer patients. So that's a whole other area that we want to branch into as a company. And it's an untapped marketplace. Well, speaking of that, you've also added two new board members since the last time I spoke to you. It sounds to me like you have a lot of people over the 50 who are vegetarian seeking this powder that are interested to be on your advisory board or your board. I should say, would you like to comment on these members? Actually, they're great members. Tracy Crook is very experienced. She has public market experience, actually worked at the TSX. She was also for nine years the chief operating officer of Canada's largest law firm. So very well tenured, knows public markets is great at governance. So it's great having her on board. And Greg Cochran is the managing director of VRG Capital, who I've known for a number of years, he's built and sold to his own marketing companies in the past. Plus he has public market experience, a ton of financial experience and building businesses. So they're great assets to bring on the board and rounds out the board nicely. I'll tell you, we would like to hear from you more often. So Stuart, please let us know in the next couple of weeks where we can get another update, but between now and say the next quarter, what should we as shareholders be looking forward to? We're at a part in our calendar right now where we build in the fall for the spring and that's the way it works in the retail environment. So right now we've got some great new product launches coming out that are all set up and they'll see those starting to hit the market come November of this year. And then distribution of those will expand out into retail come the first quarter and second quarter of next year. If you'd like to hear more information about element nutritional sciences, please do send us an email at Tracy at investor Intel. Stuart, thank you so much for joining us today and providing such a good update. Thanks very much. Appreciate it.